Clinical Trials Directory

Trials / Completed

CompletedNCT03384160

Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.

Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Splint-mouth Randomized Double Blind Controlled Clinical Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho · Academic / Other
Sex
All
Age
16 Years – 40 Years
Healthy volunteers
Accepted

Summary

The extraction of third molars, a frequent treatment in clinical dental practice, can lead patients to painful symptoms during and after surgery. The dental surgeon must correctly indicate the need for extraction and also provide patients who need this treatment greater comfort and control of pain in the trans and postoperative period. Thus, it is necessary to use an effective local anesthetic favoring the factors inherent to the postoperative and achieving good treatment results.

Detailed description

This study will compare the use of Articaine at 4% to that of Mepivacaine at 2% for lower third molar surgeries semi-included and / or included. I will select 16 patients who require surgical treatment for extraction of third molars, aged between 16 and 40 years at the São Paulo State University. These will participate simultaneously in the two groups: Group 1 mepivacaine (MEP) and Group 2 articaine (ART), and the division will be performed by randomization, so that each patient will have each side (right or left) allocated in different groups. The primary evaluation variable will be to compare the pain index in the immediate postoperative period, using Visual Analog Scale (VAS), and will also analyze Hemodynamic Parameters, such as Patient and Operator satisfaction. The results will be submitted to qualitative and quantitative statistical analysis. The descriptive data will be compared using the statistical analysis of variance (ANOVA) and Tukey test with a significance level of 5%.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGroup 1 -Pain monitorUse of the anesthetic Mepivacaine 2% in third molar extraction and evaluation in postoperative
DIAGNOSTIC_TESTGroup 2 -Pain monitorUse of the anesthetic Articaine 4% in third molar extraction and evaluation in postoperative

Timeline

Start date
2017-12-07
Primary completion
2018-10-30
Completion
2018-12-04
First posted
2017-12-27
Last updated
2019-02-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03384160. Inclusion in this directory is not an endorsement.